Questions across 2 calls

Aneesh Deora

Nomura

Fortis Healthcare Limited

Fortis Healthcare Limited CC-Sep23.pdf · 2023-11-10

So my question is around ALOS numbers. So if I look at the ALOS numbers, till the last quarter, they were in the range of 3.5, 3.6 days. But in this quarter, I think all the historical numbers have also been revised upwards to 4.2 days and something like that. So could you just tell what has exactly happened? Has there been any small change in the methodology? Or what exactly has happened there?

Okay. Is there a particular focus on reducing the ALOS further? Any particular focus there?

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. CC-Sep23.pdf · 2023-11-02

Regarding the Dengue related cases, so the news article says that the Dengue outbreak in this particular season was much more pronounced and more so in the Delhi NCR and the North India region. So, would you be able to sort of quantify the Dengue-related revenues that let’s say Dr. Lal would have seen in this quarter as against the same quarter in the previous years, any quantification there would help.

Could you may be as a percentage of revenues what were the Dengue related revenues in this quarter? Could you just maybe throw some light there?